85
Galm O, Herman JG, Baylin SB. The fundamental role of epigenetics in hematopoietic
malignancies. Blood Reviews. 2006; 20: 1-13.
Garandeau C, Pautas, E, Andreux, M, Andreux, J, Gaussem, P, Siguret, V. Myelodysplastic
syndromes. Ann. Biol. Clin. 2000; 58: 405-416.
Garcia-Manero G, Ramos-Bueso C, Daniel J, Williamson J, Kantarjian HM, Issa J J-P. DNA
methylation patterns at relapse in adult acute lymphocytic leukemia. Clin. Cancer Res. 2002;
8: 1897-1903.
Garcia-Manero G. Methylation, aging, and pediatric acute lymphocytic leukemia.
Leukemia. 2003; 17: 2063-4
Giles FJ, Stopeck, AT, Silverman, LR, Lancet, JE, Cooper, MA, Hannah, AL, Cherrington,
JM, O'Farrell, AM, Yuen, HA, Louie, SG, Hong, W, Cortes, JE, Verstovsek, S, Albitar, M,
O'Brien, SM, Kantarjian, HM, Karp, JE. SU5416, a small molecule tyrosine kinase receptor
inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or
myelodysplastic syndromes. Blood. 2003; 102: 795-801.
Giralt S. Bone marrow transplant in myelodysplastic syndromes: new technologies, same
questions. Curr Hematol Rep. 2005; 4: 200-207.
Greenberg P, Cox, C, LeBeau, MM, Fenaux, P, Morel, P, Sanz, G, Sanz, M, Vallespi, T,
Hamblin, T, Oscier, D, Ohyashiki, K, Toyama, K, Aul, C, Mufti, G, Bennett, J. International
scoring system for evaluating prognosis in myelodysplastic syndromes. Blood. 1997; 89:
2079-2088.
Gyger M, Bonny Y, Forest L. Childhood monosomy 7 syndrome. Am J Hematol. 1982; 13:
329-334
Han JY, Theil KS, Hoeltge G. Frequencies and characterization of cytogenetically unrelated
clones in various hematologic malignancies: seven years of experiences in a single institution.
Cancer Genet. Cytogenet. 2006; 164: 128-132.
Harbott J, Haas OA, Kerndrup G, Michalová K, Sainati L, Slater R, Biondi A, Fenu S, Hasle
H, Kühne T, Mann G, Stary J, Van Wering ER, Baumann I, Nöllke P, Rogge T, Zimmermann
M, Niemeyer C. Cytogenetic evaluation of children with MDS and JMML. Results of the
European working group of childhood MDS (EWOG-MDS). Leukemia. 2000; 14-961.